- Home
- RAYA vs PYXS Comparison
RAYA vs PYXS Comparison
Compare RAYA & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAYA
- PYXS
- Stock Information
- Founded
- RAYA 2019
- PYXS 2018
- Country
- RAYA China
- PYXS United States
- Employees
- RAYA N/A
- PYXS N/A
- Industry
- RAYA Metal Fabrications
- PYXS Biotechnology: Pharmaceutical Preparations
- Sector
- RAYA Consumer Discretionary
- PYXS Health Care
- Exchange
- RAYA Nasdaq
- PYXS Nasdaq
- Market Cap
- RAYA 89.2M
- PYXS 75.0M
- IPO Year
- RAYA 2022
- PYXS 2021
- Fundamental
- Price
- RAYA $2.52
- PYXS $1.16
- Analyst Decision
- RAYA
- PYXS Strong Buy
- Analyst Count
- RAYA 0
- PYXS 5
- Target Price
- RAYA N/A
- PYXS $9.00
- AVG Volume (30 Days)
- RAYA 249.4K
- PYXS 729.3K
- Earning Date
- RAYA 01-01-0001
- PYXS 08-13-2025
- Dividend Yield
- RAYA N/A
- PYXS N/A
- EPS Growth
- RAYA N/A
- PYXS N/A
- EPS
- RAYA N/A
- PYXS N/A
- Revenue
- RAYA $30,300,360.00
- PYXS N/A
- Revenue This Year
- RAYA $20.95
- PYXS N/A
- Revenue Next Year
- RAYA N/A
- PYXS N/A
- P/E Ratio
- RAYA N/A
- PYXS N/A
- Revenue Growth
- RAYA 49.10
- PYXS N/A
- 52 Week Low
- RAYA $0.56
- PYXS $0.83
- 52 Week High
- RAYA $3.14
- PYXS $5.39
- Technical
- Relative Strength Index (RSI)
- RAYA 58.75
- PYXS 49.80
- Support Level
- RAYA $2.31
- PYXS $1.04
- Resistance Level
- RAYA $3.14
- PYXS $1.24
- Average True Range (ATR)
- RAYA 0.37
- PYXS 0.09
- MACD
- RAYA 0.03
- PYXS -0.01
- Stochastic Oscillator
- RAYA 57.82
- PYXS 48.21
About RAYA Erayak Power Solution Group Inc.
Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.